• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环丙沙星在囊性纤维化患者治疗中的应用。

The use of ciprofloxacin in the treatment of patients with cystic fibrosis.

作者信息

van den Broek P J, Bakker W, Mattie H, van Gulpen C

机构信息

Department of Infectious Diseases, University Hospital Building 1, Leiden, The Netherlands.

出版信息

Pharm Weekbl Sci. 1987 Dec 11;9 Suppl:S68-71. doi: 10.1007/BF02075265.

DOI:10.1007/BF02075265
PMID:3438152
Abstract

The use of ciprofloxacin for the treatment of pulmonary infection in cystic fibrosis patients was investigated. Therapy was successful in six patients and unsuccessful in three patients. In one patient therapy had to be stopped because serum transaminase levels showed a 5- to 8- fold increase. During therapy resistance developed in Haemophilus influenzae, Staphylococcus aureus and Pseudomonas aeruginosa.

摘要

对环丙沙星用于治疗囊性纤维化患者肺部感染进行了研究。治疗对6例患者有效,对3例患者无效。在1例患者中,由于血清转氨酶水平升高了5至8倍,不得不停止治疗。治疗期间,流感嗜血杆菌、金黄色葡萄球菌和铜绿假单胞菌产生了耐药性。

相似文献

1
The use of ciprofloxacin in the treatment of patients with cystic fibrosis.环丙沙星在囊性纤维化患者治疗中的应用。
Pharm Weekbl Sci. 1987 Dec 11;9 Suppl:S68-71. doi: 10.1007/BF02075265.
2
Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis.环丙沙星两种给药方案治疗囊性纤维化患者慢性支气管肺部感染的随机研究。
Am J Med. 1987 Apr 27;82(4A):189-95.
3
Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.儿童囊性纤维化的环丙沙星序贯疗法:与头孢他啶/妥布霉素治疗急性肺部加重期的对比研究。囊性纤维化研究组
Pediatr Infect Dis J. 1997 Jan;16(1):97-105; discussion 123-6. doi: 10.1097/00006454-199701000-00031.
4
In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.对可用于囊性纤维化(CF)患者肺部感染口服治疗的药物抗菌活性的体外研究。
J Antimicrob Chemother. 1998 Aug;42(2):171-8. doi: 10.1093/jac/42.2.171.
5
Treatment of serious infections with intravenous ciprofloxacin.
Am J Med. 1987 Apr 27;82(4A):369-75.
6
Fluoroquinolones in the treatment of cystic fibrosis.氟喹诺酮类药物在囊性纤维化治疗中的应用
Drugs. 1993;45 Suppl 3:98-101. doi: 10.2165/00003495-199300453-00017.
7
Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches.铜绿假单胞菌和金黄色葡萄球菌对环丙沙星的紧急耐药性:临床意义及治疗方法
J Antimicrob Chemother. 1990 Dec;26 Suppl F:165-79. doi: 10.1093/jac/26.suppl_f.165.
8
Efficacy of ciprofloxacin in patients with cystic fibrosis.环丙沙星对囊性纤维化患者的疗效。
Drug Intell Clin Pharm. 1988 Jul-Aug;22(7-8):551-3. doi: 10.1177/106002808802200705.
9
[Antibiotic treatment of cystic fibrosis exacerbations].[囊性纤维化急性加重期的抗生素治疗]
Medicina (Kaunas). 2003;39(3):221-4.
10
Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.亚优化环丙沙星剂量可能导致囊性纤维化患儿铜绿假单胞菌敏感性降低。
Pharmacotherapy. 2010 Dec;30(12):1252-8. doi: 10.1592/phco.30.12.1252.

本文引用的文献

1
Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis.
Lancet. 1987 Jan 31;1(8527):235-7. doi: 10.1016/s0140-6736(87)90062-6.
2
Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa.口服环丙沙星治疗铜绿假单胞菌感染
Lancet. 1986 Apr 12;1(8485):819-22. doi: 10.1016/s0140-6736(86)90937-2.